KURE Top Holdings & Constituents
KURE, offered by CICC, holds 53 reported positions across $79.6M in assets. Its largest holdings are INNOVENT BIOLOGICS, INC. (8.69%), BeOne Medicines AG (8.17%), and WUXI BIOLOGICS (CAYMAN) INC. (6.63%). The 5 biggest positions account for 34.91% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
— INNOVENT BIOLOGICS, INC. | 8.69% | $6.98M |
— BeOne Medicines AG | 8.17% | $6.57M |
— WUXI BIOLOGICS (CAYMAN) INC. | 6.63% | $5.33M |
— Akeso Inc | 5.74% | $4.62M |
— WuXi AppTec Co., Ltd. | 5.68% | $4.57M |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended Mar 31, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.